Start Date
October 31, 2002
Primary Completion Date
June 30, 2005
Study Completion Date
June 30, 2005
Investigational Cancer Drug
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Baltimore
GSK Investigational Site, Salem
GSK Investigational Site, Durham
GSK Investigational Site, Greenville
GSK Investigational Site, Hickory
GSK Investigational Site, Columbia
GSK Investigational Site, Savannah
GSK Investigational Site, Plantation
GSK Investigational Site, Fort Myers
GSK Investigational Site, Nashville
GSK Investigational Site, Nashville
GSK Investigational Site, Memphis
GSK Investigational Site, Memphis
GSK Investigational Site, Germantown
GSK Investigational Site, Royal Oak
GSK Investigational Site, Des Moines
GSK Investigational Site, Bettendorf
GSK Investigational Site, Fargo
GSK Investigational Site, Billings
GSK Investigational Site, Park Ridge
GSK Investigational Site, Skokie
GSK Investigational Site, Skokie
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Tulsa
GSK Investigational Site, Houston
GSK Investigational Site, Los Angeles
GSK Investigational Site, Chula Vista
GSK Investigational Site, Poway
GSK Investigational Site, Hooksett
Lead Sponsor
GlaxoSmithKline
INDUSTRY